CA1322160C - Therapeutic use of enkephalinase - Google Patents

Therapeutic use of enkephalinase

Info

Publication number
CA1322160C
CA1322160C CA 555184 CA555184A CA1322160C CA 1322160 C CA1322160 C CA 1322160C CA 555184 CA555184 CA 555184 CA 555184 A CA555184 A CA 555184A CA 1322160 C CA1322160 C CA 1322160C
Authority
CA
Canada
Prior art keywords
enkephalinase
medicament
administration
pathological disorder
endogenous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA 555184
Other languages
English (en)
French (fr)
Inventor
Bernard Malfroy-Camine
Daniel Benjamin Borson
Jay Alan Nadel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
University of California
Original Assignee
Genentech Inc
University of California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc, University of California filed Critical Genentech Inc
Application granted granted Critical
Publication of CA1322160C publication Critical patent/CA1322160C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA 555184 1986-12-24 1987-12-23 Therapeutic use of enkephalinase Expired - Fee Related CA1322160C (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US94656686A 1986-12-24 1986-12-24
US06/946,566 1986-12-24
US247387A 1987-01-12 1987-01-12
US07/002,473 1987-01-12
US11777987A 1987-11-05 1987-11-05
US07/117,779 1987-11-05

Publications (1)

Publication Number Publication Date
CA1322160C true CA1322160C (en) 1993-09-14

Family

ID=27357171

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 555184 Expired - Fee Related CA1322160C (en) 1986-12-24 1987-12-23 Therapeutic use of enkephalinase

Country Status (6)

Country Link
CA (1) CA1322160C (da)
DE (1) DE3751748T2 (da)
DK (1) DK684487A (da)
IE (1) IE873536L (da)
IL (1) IL84929A (da)
NZ (1) NZ223029A (da)

Also Published As

Publication number Publication date
DE3751748T2 (de) 1996-11-14
IE873536L (en) 1988-06-24
DK684487A (da) 1988-10-07
DK684487D0 (da) 1987-12-23
DE3751748D1 (de) 1996-04-25
NZ223029A (en) 1991-02-26
IL84929A (en) 1993-04-04

Similar Documents

Publication Publication Date Title
Ownby et al. Lysine 49 phospholipase A2 proteins
Reid Is there a brain renin-angiotensin system?
Liu-Chen et al. Immunohistochemical evidence for a substance P-containing trigeminovascular pathway to pial arteries in cats
Brady et al. The metabolism of sphingomyelin. II. Evidence of an enzymatic deficiency in Niemann-Pick diseae.
Sekizawa et al. Role of substance P in cough
AU1424399A (en) Pharmaceutical composition comprising phosphatase or a derivative thereof
JP2001514232A (ja) 細胞外亜鉛スフィンゴミエリナーゼに関連した症状に罹患した対象を治療する方法
Piedimonte et al. Neutral endopeptidase and kininase II mediate glucocorticoid inhibition of neurogenic inflammation in the rat trachea.
Marcus et al. Growth hormone increases the lipolytic sensitivity for catecholamines in adipocytes from healthy adults
JP2013234193A (ja) 生理学的過程の調節およびこれに有用な薬剤
JP2002504988A (ja) ニューロンヘの炎症性損傷を防ぐ薬剤の同定法
KR20010015757A (ko) 박테리아 정착 제어용 조성물
Grutzner et al. Effect of injury on pulpal levels of immunoreactive substance P and immunoreactive calcitonin gene-related peptide
US20040152868A1 (en) Compositions and methods for modulating guanylyl cyclase signaling receptor (gc-c) activity and for treating meniere's disease
US5262178A (en) Therapeutic use of enkephalinase
Gimbrone Jr et al. Angiotensin-converting enzyme activity in isolated brain microvessels
JP2015536658A (ja) 標的化イズロン酸−２−スルファターゼ化合物
Jouquey et al. Effect of chronic treatment with trandolapril or enalapril on brain ACE activity in spontaneously hypertensive rats
CA1322160C (en) Therapeutic use of enkephalinase
WO2012147933A1 (ja) リソソーム病治療用医薬組成物
BR112013007557A2 (pt) peptídeos nd2 e seu uso no tratamento de doenças neurológicas
Valle et al. Gyrate atrophy of the choroid and retina in a cat.
Dartt et al. Stimulation of rabbit lacrimal gland secretion with biologically active peptides
Togo et al. D-Phe7-substituted peptide bradykinin antagonists are not substrates for kininase II
Sambhi et al. Renin activation in the venous plasma from the involved kidney in the patient with renal hypertension

Legal Events

Date Code Title Description
MKLA Lapsed